Porton Pharma Solutions Ltd. (SHE:300363)
China
· Delayed Price · Currency is CNY 14.96
+0.29 (1.98%)
Apr 28, 2025, 2:45 PM CST
Porton Pharma Solutions Revenue
Porton Pharma Solutions had revenue of 801.16M CNY in the quarter ending March 31, 2025, with 18.51% growth. This brings the company's revenue in the last twelve months to 3.14B, up 5.66% year-over-year. In the year 2024, Porton Pharma Solutions had annual revenue of 3.01B, down -17.87%.
Revenue (ttm)
3.14B
Revenue Growth
+5.66%
P/S Ratio
2.55
Revenue / Employee
637.93K
Employees
4,915
Market Cap
8.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.01B | -655.45M | -17.87% |
| Dec 31, 2023 | 3.67B | -3.37B | -47.87% |
| Jan 1, 2023 | 7.03B | 3.93B | 126.55% |
| Jan 1, 2022 | 3.11B | 1.03B | 49.87% |
| Dec 31, 2020 | 2.07B | 520.58M | 33.56% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.77B |
| Aier Eye Hospital Group | 20.98B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.30B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |